Cimeio: Cimeio Therapeutics Presents Data for its CD45 Universal Heme ADC at ASH

--Preclinical data for Cimeio's CD45 universal heme ADC and shielded HSCs demonstrate effective depletion of an aggressive AML cell line in vivo-- --First data for Cimeio's CD33 shielded HSCs show...